ViroGates (Denmark) Today
| VIRO Stock | 13.70 0.60 4.20% |
Performance13 of 100
| Odds Of DistressOver 55
|
ViroGates is selling at 13.70 as of the 1st of December 2024; that is 4.2 percent down since the beginning of the trading day. The stock's open price was 14.3. ViroGates has over 55 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat good returns during the last 90 days. Equity ratings for ViroGates AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2023 and ending today, the 1st of December 2024. Click here to learn more.
Moving together with ViroGates Stock
Moving against ViroGates Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ViroGates Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ViroGates' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ViroGates or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Devices, Healthcare (View all Sectors) |
ViroGates AS (VIRO) is traded on Copenhagen Exchange in Denmark and employs 10 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 191.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ViroGates's market, we take the total number of its shares issued and multiply it by ViroGates's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ViroGates AS operates under Healthcare sector and is part of Medical Devices industry. The entity has 3.35 M outstanding shares.
ViroGates generates negative cash flow from operations
Check ViroGates Probability Of Bankruptcy
Ownership AllocationThe market capitalization of ViroGates is USD191.08 Million. ViroGates AS maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check ViroGates Ownership Details
ViroGates AS Risk Profiles
Although ViroGates' alpha and beta are two of the key measurements used to evaluate ViroGates' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.06 | |||
| Semi Deviation | 7.93 | |||
| Standard Deviation | 11.36 | |||
| Variance | 129.09 |
ViroGates Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in ViroGates without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
ViroGates Corporate Management
Elected by the shareholders, the ViroGates' board of directors comprises two types of representatives: ViroGates inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ViroGates. The board's role is to monitor ViroGates' management team and ensure that shareholders' interests are well served. ViroGates' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ViroGates' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Krarup | VP Marketing | Profile | |
| Mark Silva | Chief Officer | Profile | |
| Jakob Knudsen | Chief Officer | Profile | |
| Jesper EugenOlsen | CoFounder Officer | Profile | |
| May Dyvelkov | VP Accounting | Profile |
Other Information on Investing in ViroGates Stock
ViroGates financial ratios help investors to determine whether ViroGates Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ViroGates with respect to the benefits of owning ViroGates security.